.
.
.
Results for
Pfizer
178 Results-
Explainer: Some patients reporting COVID rebounds after taking Pfizer pills
More than 2.8 million courses of Pfizer Inc’s COVID-19 oral antiviral treatment Paxlovid have been made available at pharmacies around the United ... Coronavirus -
Pfizer to spend $11.6B on migraine treatment maker Biohaven
Pfizer is spending more than $11.6 billion to buy the remaining portion of migraine treatment maker Biohaven Pharmaceuticals it does not already ... Financial Markets -
J&J suspends sales forecast for COVID-19 vaccine, cuts profit view
Johnson & Johnson on Tuesday cut its full-year profit expectation and suspended sales forecast for its COVID-19 vaccine after having earlier predicted ... Coronavirus -
Pfizer to expand COVID-19 booster shots to healthy five to 11-year-olds in US
Pfizer said Thursday it wants to expand its COVID-19 booster shots to healthy elementary-age kids.US health authorities already urge everyone 12 and ... Coronavirus -
Pfizer to buy lung-focused biotech developer ReViral for as much as $525 mln
Pfizer Inc. agreed to buy respiratory antiviral developer ReViral Ltd. for as much as $525 million, the COVID-19 vaccine maker’s latest move in the ... Business -
Current COVID-19 vaccines not ‘well-matched’ against BA.2: FDA
Current COVID-19 vaccines are not well-matched against the BA.2 sub-variant of omicron, the US Food and Drug Administration said on Wednesday, as its ... Coronavirus -
China approves Pfizer’s COVID pill Paxlovid for mild to moderate cases
China’s medical products regulator said on Saturday it has given conditional approval for Pfizer’s COVID-19 drug Paxlovid, making it the first oral ... World News -
Pfizer, UAE renew partnership to deal with cancer incidence, spread awareness
Pfizer has renewed its partnerships with United Arab Emirates-based cancer patient societies Friends of Cancer Patients (FOCP) and Emirates Oncology ... Gulf -
Pfizer-BioNTech begin omicron COVID-19 vaccine trial: Statement
Pfizer and BioNTech have begun enrollment for a clinical trial to test the safety and immune response of their omicron-specific COVID-19 vaccine in ... Coronavirus -
Africa CDC talking to Pfizer about importing its COVID-19 treatment pill
Africa’s top public health body is in talks with Pfizer about bringing in supplies of its antiviral Paxlovid treatment pills for COVID-19 to the ... Coronavirus -
Pfizer study shows COVID-19 booster can be given along with pneumonia shot
Pfizer said on Wednesday booster doses of its COVID-19 vaccine can be administered along with its pneumonia vaccine and produced strong safety and ... Coronavirus -
New Zealand links 26-year-old man’s death to Pfizer COVID-19 vaccine
New Zealand authorities on Monday said they had linked a 26-year-old man’s death to Pfizer Inc’s COVID-19 vaccine after the person suffered ... Coronavirus -
Pfizer set to oust AstraZeneca as top supplier of COVID-19 vaccines to poor nations
Pfizer and BioNtech are set to displace AstraZeneca as the main suppliers of COVID-19 vaccines to the global COVAX program at the start of 2022, a ... Coronavirus -
Pfizer confirms experimental COVID pill appears effective against omicron variant
Pfizer said Tuesday that its experimental COVID-19 pill appears effective against the omicron variant.The company also said full results of its ... Coronavirus -
US authorizes Pfizer, Moderna COVID-19 boosters for all over 18s
The United States on Friday authorized Pfizer and Moderna COVID-19 vaccine boosters to all people aged 18 and older, the Food and Drug Administration ... Coronavirus -
Pfizer signs $5.3 billion COVID-19 oral antiviral drug deal with US government
Pfizer Inc has signed a $5.29 billion deal with the US government to deliver 10 million courses of its COVID-19 oral antiviral drug starting this year ... Coronavirus -
Pfizer to allow generic versions of its COVID-19 pill paxlovid in 95 countries
Pfizer Inc said on Tuesday it will allow generic manufacturers to supply its experimental antiviral COVID-19 pill to 95 low- and middle-income ... Coronavirus -
Pfizer shot generates most COVID-fighting antibodies: Comparative study
Pfizer Inc. and BioNTech SE’s COVID-19 shot yielded the strongest immune response among four vaccines tested in a study, which found people getting ... Coronavirus -
Explainer: How does Merck’s COVID-19 pill compare to Pfizer’s?
Pfizer Inc and Merck & Co Inc have developed experimental antiviral pills that have shown promising efficacy in trials of adults with COVID-19 who are ... Coronavirus -
Pfizer says its antiviral pill cuts risk of severe COVID-19 by 89 percent
A trial of Pfizer Inc’s experimental antiviral pill for COVID-19 was stopped early after the drug was shown to cut by 89 percent the chances of ... Coronavirus -
Bahrain approves Pfizer COVID-19 vaccine for children aged 5-11
Gulf state Bahrain has approved the Pfizer COVID-19 vaccine for emergency use for children aged between 5 and 11 years, the government media office ... Coronavirus -
UAE grants emergency use approval of Pfizer COVID-19 vaccine for ages 5 to 11
The United Arab Emirates has approved for emergency use the Pfizer-BioNtech COVID-19 vaccine for children aged 5-11, the health ministry said in a ... Coronavirus -
Pfizer COVID-19 vaccine shows over 90 pct efficacy in trial in children
The Pfizer/BioNTech COVID-19 vaccine showed 90.7 percent efficacy against the coronavirus in a clinical trial of five to 11-year-olds, the US ... Coronavirus -
Malaysia approves Pfizer COVID-19 vaccine as booster shot
Malaysia has granted conditional approval for the COVID-19 vaccine made by Pfizer and BioNTech to be used as a booster shot, the health ministry said ... Coronavirus -
Pfizer, BioNTech ask US regulators to approve COVID-19 vaccine for kids
Pfizer Inc and BioNTech said on Thursday they had asked US regulators to approve emergency use of their COVID-19 vaccine for children aged from five ... Coronavirus -
US eyes Israeli military data for Pfizer COVID-19 booster safety
US health officials are hoping data on Israeli military personnel can help clarify the risk of heart muscle inflammation in younger people who have ... Coronavirus -
Heart inflammation rates higher after Moderna COVID-19 shot than Pfizer: Data
Canadian health officials said on Friday data suggests reported cases of rare heart inflammation were relatively higher after Moderna's COVID-19 ... Coronavirus -
Egypt receives first 1.6 mln doses of Pfizer COVID-19 vaccine from US
Egypt on Thursday received 1.6 million doses of the COVID-19 vaccine produced by Pfizer as a gift from the United States as part of the COVAX ... Coronavirus -
Pfizer tests COVID-19 pill as preventive medicine
Pfizer has started testing its potential COVID-19 treatment as a preventive medicine aimed at warding off the virus if a close contact gets it.The ... Coronavirus -
US President Biden to get COVID-19 vaccine booster shot later Monday: White House
US President Joe Biden received his COVID-19 vaccine booster shot Monday, days after US health experts recommended the third jab for people over the ... Coronavirus